U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07893314) titled 'Effects of Food Intake on Biomarker Activity in Normal Humans Taking Immulina' on Oct. 15.
Brief Summary: The need for a generally available product that can safely and effectively increase antiviral resilience in susceptible populations became highly relevant during the recent COVID pandemic. The value continues with the endemic influenza season, which is now joined by COVID and, in susceptible adults, respiratory syncytial virus. The investigators recently completed a NIH-funded U19 project examining the immune potentiating effects of Immulina supplementation on biomarkers associated with antiviral resilience. Results showed robus...